Dr. Lydia Scarfò is a physician scientist at the B-cell neoplasia Unit and an assistant professor at Università Vita-Salute San Raffaele, Milano, Italy.
June 27, 2025
Video
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, per Dr. Lydia Scarfò.
Managing Lynch Syndrome
New Directions in Treatment for Patients With GIST
More Patients Are Living Beyond Liver Cancer Thanks to Expanding Care
Living With Leukemia Chester Freeman Embraces Wabi-Sabi